
Sign up to save your podcasts
Or


Send us a text
Mel interviews Karina Sergi, MS, MFT Director, Psychedelic Therapy Training; Director, Diversity, Equity & Inclusion and Keith Heinzerling, MD Director, Treatment & Research In Psychedelics (TRIP) Center; Addiction Medicine.
We discuss psychedelic associated therapy, ketamine, DMT, Psilocybin, Hallucinogen persisting perception disorder (HPPD, Ontological shock, Psychnaughts and so much more as we continue our series on mental health treatment options
The Treatment and Research in Psychedelics clinic (TRIP) located at Pacific Neuroscience Institute. Their website:
https://www.pacificneuroscienceinstitute.org/treatment-research-in-psychedelics/
Support the show
By Mel Herbert for FoolyBoo Inc5
1717 ratings
Send us a text
Mel interviews Karina Sergi, MS, MFT Director, Psychedelic Therapy Training; Director, Diversity, Equity & Inclusion and Keith Heinzerling, MD Director, Treatment & Research In Psychedelics (TRIP) Center; Addiction Medicine.
We discuss psychedelic associated therapy, ketamine, DMT, Psilocybin, Hallucinogen persisting perception disorder (HPPD, Ontological shock, Psychnaughts and so much more as we continue our series on mental health treatment options
The Treatment and Research in Psychedelics clinic (TRIP) located at Pacific Neuroscience Institute. Their website:
https://www.pacificneuroscienceinstitute.org/treatment-research-in-psychedelics/
Support the show

32,332 Listeners

30,839 Listeners

15,940 Listeners

1,870 Listeners

550 Listeners

259 Listeners

2,457 Listeners

277 Listeners

9,584 Listeners

8,746 Listeners

329 Listeners

260 Listeners

280 Listeners

58 Listeners

6 Listeners